PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
23-Sep-2024 Glocal Cannabis Nursing Institute (GCNI) Expands Horizons: A Comprehensive Approach to Interprofessional Cannabis Education, Clinical Practicums, Research, and Advocacy Leading to International Research, Practice and Employment Opportunities in Global Cannabis Nursing AccessWire
23-Sep-2024 Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options AccessWire
23-Sep-2024 Avant Brands Expands Global Footprint with BLK MKT(TM) Launch in Australia AccessWire
23-Sep-2024 Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024 Heidelberg Pharma AG
23-Sep-2024 Science & Humans Proudly Welcomes Renowned Healthcare Leader Karim "Matt" Nassar as Chief Growth Officer AccessWire
23-Sep-2024 Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System AccessWire
23-Sep-2024 Biotech developing ‘dialysis breakthrough’ treatment raises further funds Invizius
23-Sep-2024 Pentixapharm Holding AG Sets Price Range for Planned IPO Pentixapharm Holding AG
23-Sep-2024 Apprentice.io Announces New AI-Powered Capabilities at European Pharma Event and Offers a Free Trial of Its Tempo Manufacturing Cloud Newswire
23-Sep-2024 Being Green and Sustainable: Alfa Chemistry Provides Biobased Pharmaceutical Chemicals, Plasticizers, and Biofuels Alfa Chemistry
23-Sep-2024 Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia Teva Pharmaceutical Industries Ltd
23-Sep-2024 Healthcare Fraud Detection: A Strategic Imperative for Business Leaders Mastech InfoTrellis
23-Sep-2024 Angle PLC Announces Exclusive agreement for DNA NGS panel AccessWire
23-Sep-2024 Relief Therapeutics Announces $2 Million Milestone Under Royalty Sales Agreement Relief Therapeutics Holding SA
20-Sep-2024 Integrated BioPharma Reports Results for Its Quarter and Fiscal Year Ended June 30, 2024 AccessWire
20-Sep-2024 AI/ML Innovations Inc. Provides Second Status Update AccessWire
20-Sep-2024 Leafbuyer Technologies, Inc. Announces Quarterly Results AccessWire
20-Sep-2024 Dr. Vitenas Provides Insight Into Emerging 'Yoga' or 'Ballerina' Breast Augmentation Trend AccessWire
20-Sep-2024 BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator BRAIN Biotech AG
20-Sep-2024 BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma BRAIN Biotech AG